D Magazine3d
UNTHSC Names Permanent TCOM Dean and Alpha Cognition Commercializes Alzheimer’s Drug
Plus Texas Health's Surgery Recognition and Medical City Fort Worth's Expansion Milestone.
Dr Boreham’s Crucible: This rare blood disease tackler aims to hit investors with its best shot
While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...